V029-5874 Screening compound: 4-tert-butyl-N-[2-(4-ethylpiperazine-1-carbonyl)-1-[(3-methylphenyl)methyl]-1H-indol-5-yl]benzene-1-sulfonamide

V029-5874 Screening compound: 4-tert-butyl-N-[2-(4-ethylpiperazine-1-carbonyl)-1-[(3-methylphenyl)methyl]-1H-indol-5-yl]benzene-1-sulfonamide
V029-5874 Screening compound: 4-tert-butyl-N-[2-(4-ethylpiperazine-1-carbonyl)-1-[(3-methylphenyl)methyl]-1H-indol-5-yl]benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-5874
4-tert-butyl-N-[2-(4-ethylpiperazine-1-carbonyl)-1-[(3-methylphenyl)methyl]-1H-indol-5-yl]benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-5874

Molecular Formula

C33H40N4O3S (C33 H40 N4 O3 S)

Compound Name

4-tert-butyl-N-[2-(4-ethylpiperazine-1-carbonyl)-1-[(3-methylphenyl)methyl]-1H-indol-5-yl]benzene-1-sulfonamide

IUPAC name

4-tert-butyl-N-[2-(4-ethylpiperazine-1-carbonyl)-1-[(3-methylphenyl)methyl]-1H-indol-5-yl]benzene-1-sulfonamide

SMILES

CCN(CC1)CCN1C(c1cc(cc(cc2)NS(c3ccc(C(C)(C)C)cc3)(=O)=O)c2n1Cc1cc(C)ccc1)=O

InChI

InChI=1S/C33H40N4O3S/c1-6-35-16-18-36(19-17-35)32(38)31-22-26-21-28(12-15-30(26)37(31)23-25-9-7-8-24(2)20-25)34-41(39,40)29-13-10-27(11-14-29)33(3,4)5/h7-15,20-22,34H,6,16-19,23H2,1-5H3

InChI Key

DGJKGALZVBGROY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19777619

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

572.77

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.945

Distribution Coefficient, logD

6.764

Water Solubility, LogSw

-5.79

Polar Surface Area

61.527

Acid Dissociation Constant (pKa)

9.42

Base Dissociation Constant (pKb)

7.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.40

V029-5874 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

CORONAVIRUS Library (20774 compounds)

Indole Derivatives (10091 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Structure:
  • Cyclic compounds
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V029-5874 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-5874?
Check Price and Availability of V029-5874, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-5874 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-5874
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-5874
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-5874 available by request